4D Molecular Therapeutics, Inc. (FDMT)
8.61
-0.37
(-4.12%)
USD |
NASDAQ |
Mar 20, 16:00
8.63
+0.02
(+0.23%)
After-Hours: 20:00
4D Molecular Therapeutics Profit Margin (Quarterly) : 22.80% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -5.20% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.78% |
| Return on Assets | -27.58% |
| Return on Invested Capital | -29.30% |
| Gross Profit Margin (Quarterly) | 97.67% |
| Operating Margin (Quarterly) | 17.29% |
| Return on Net Operating Assets | -378.8% |